About this Journal Submit a Manuscript Table of Contents
Journal of Ophthalmology
Volume 2012 (2012), Article ID 576712, 5 pages
http://dx.doi.org/10.1155/2012/576712
Clinical Study

Adverse Effects of Systemic Immunosuppression in Keratolimbal Allograft

Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, 1855 West Taylor Street, Chicago, IL 60612, USA

Received 10 November 2011; Accepted 22 December 2011

Academic Editor: Andrew G. Lee

Copyright © 2012 M. Krakauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Y. Kim, A. R. Djalilian, G. S. Schwartz, and E. J. Holland, “Ocular surface reconstruction: limbal stem cell transplantation,” Ophthalmology Clinics of North America, vol. 16, no. 1, pp. 67–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. E. J. Holland, A. R. Djalilian, and G. S. Schwartz, “Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique,” Ophthalmology, vol. 110, no. 1, pp. 125–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Ekberg, H. Tedesco-Silva, A. Demirbas et al., “Reduced exposure to calcineurin inhibitors in renal transplantation,” The New England Journal of Medicine, vol. 357, no. 25, pp. 2562–2575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Denton, C. C. Magee, and M. H. Sayegh, “Immunosuppressive strategies in transplantation,” The Lancet, vol. 353, no. 9158, pp. 1083–1091, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Biber, H. M. Skeens, K. D. Neff, and E. J. Holland, “The cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure,” Cornea, vol. 30, no. 7, pp. 765–771, 2011. View at Publisher · View at Google Scholar
  6. R. R. Alloway, G. Mogilishetty, L. Cole, et al., “Ocular surface transplant recipients experience fewer immunosuppression complications than renal transplant recipients: implications for facial and composite tissue transplantation,” American Journal of Transplantation, vol. 455, p. 266, 2007.
  7. L. Liang, H. Sheha, and S. C. G. Tseng, “Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits,” Archives of Ophthalmology, vol. 127, no. 11, pp. 1428–1434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Kempen, E. Daniel, J. P. Dunn et al., “Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.,” British Medical Journal, vol. 339, article b2480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. O. Kaçmaz, J. H. Kempen, C. Newcomb et al., “Cyclosporine for ocular inflammatory diseases,” Ophthalmology, vol. 117, no. 3, pp. 576–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Daniel, J. E. Thorne, C. W. Newcomb et al., “Mycophenolate mofetil for ocular inflammation,” American Journal of Ophthalmology, vol. 149, no. 3, pp. 423–e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Joseph, D. Raj, V. Shanmuganathan, R. J. Powell, and H. S. Dua, “Tacrolimus immunosuppression in high-risk corneal grafts,” British Journal of Ophthalmology, vol. 91, no. 1, pp. 51–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Reinhard, A. Reis, D. Böhringer et al., “Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 239, no. 5, pp. 367–372, 2001. View at Scopus
  13. A. C. Poon, J. E. Forbes, J. K. G. Dart et al., “Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study,” British Journal of Ophthalmology, vol. 85, no. 12, pp. 1464–1469, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Reinhard, H. Spelsberg, L. Henke et al., “Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency,” Ophthalmology, vol. 111, no. 4, pp. 775–782, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Spelsberg, T. Reinhard, L. Henke, P. Berschick, and R. Sundmacher, “Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results,” Ophthalmology, vol. 111, no. 8, pp. 1528–1533, 2004. View at Publisher · View at Google Scholar · View at Scopus